Tag | Content |
---|
EnhancerAtlas ID | HS105-22221 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr13:46943160-46944060 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Foxd3 | MA0041.1 | chr13:46943818-46943830 | AAACAAACATTT | - | 6.27 |
|
| Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
SE_10381 | chr13:46942847-46945176 | CD19_Primary | SE_11021 | chr13:46938988-46966310 | CD20 | SE_58380 | chr13:46942494-46980019 | Ly1 | SE_58841 | chr13:46942598-46965232 | Ly3 | SE_61066 | chr13:46943466-46976566 | HBL1 | SE_61451 | chr13:46941600-46980495 | Toledo | SE_62524 | chr13:46942817-46976452 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH13I046368 | chr13 | 46943097 | 46945018 |
|
Enhancer Sequence | GGAGTAACTG GGAGGTATCC TCAGCCACCG GAGTGGAGGA GACCAATGAG GAAAAGAGGG 60 TAGAAAGAGA ATAGGGTCCT GGGAAATCCC AACAGGGGCT GGGGTAAAGT GAGAAGCCAC 120 AGTCCAAAAG CAGGGTCCTA AGGATTATGA GATCGCTTCT CTAGCTCATT GTGATTGATC 180 TTAAACTTCC TTTCTTCTTC TTCTTTTGAG ACAATATCTC GCTCTGTCAC CCAGGCTAGA 240 GTGCAGCGGC GTGATCACAC TTTAGTGCGG CTTCAACCTC CTGGGCTCAA GCGATTCTTC 300 TACCTCAGCC TCCCTAGCAG CTGAGATTAC AGGTGCCACC ATGACCAGCT GATTTTCTAA 360 ATTATTTTTG CAGAGATGGG GGTCTCATTA GCTTGCCCAG GCTGGTCTCA AATCACTGGG 420 CTCAAGCTAT CCTTCCACCT CAGCCTCTCA AAGCACTGAG ATTACAGGCA GATTGAGCCA 480 CTGCACCCAG CCCTAAACCT CCTGTCTAGA GAAATAAAAT CCATCCAAAA AAGGTCAGCA 540 TTGCTTCTCT AAGTTAGTCT TCTTCCAGTC AAAACCAACA AACTGCAGAA GGTACATTCT 600 GCTGACACAT CCATTCCTGC ACCCTTAGCC ACTCCATTAC TGGCAATGAC CACCATCAAA 660 ACAAACATTT TTTCTGTCAT GTGATTTCTT ACTGCAGCAT TTAAAGCAAA AATTTCTGTG 720 TCAAGAGCTG AGATGTCCCA ACCTGCTAAA TTAGAACAAA ATGCTGCACA TGGTGGTGAC 780 ACAGCTCTCA GCATGATGGA GTTGCAAGCA GAGTCATTCA AATCCCTTGC TTCATGTTCA 840 AGAAAGTAGT TGTTGCATGG AAAAATTTGG ACTTCTTAGC TTCAGAAGCT ATGGCTGGCA 900
|